Emma Walmsley
Chief Executive Officer at GSK PLC
Net worth: 49 M $ as of 2024-05-30
Profile
Emma N.
Walmsley is currently the Chief Executive Officer & Executive Director at GSK Plc since 2017.
She is also the Chief Executive Officer at GlaxoSmithKline Australia Pty Ltd.
Additionally, she serves as an Independent Director at Microsoft Corp.
and as a Member at Stanford Medicine.
Previously, Ms. Walmsley held the position of Chief Executive Officer at GlaxoSmithKline Consumer Healthcare Pte Ltd.
and GlaxoSmithKline Consumer Healthcare Holdings Ltd.
She was also a Non-Executive Director at Diageo Plc in 2016.
Furthermore, she worked as the General Manager-Consumer Products at L'Oreal (China) Co., Ltd.Ms. Walmsley completed her graduate degree at the University of Oxford.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GSK PLC
0.05% | 2024-06-10 | 1,976,146 ( 0.05% ) | 44 M $ | 2024-05-30 |
MICROSOFT CORPORATION
0.00% | 2024-06-06 | 9,914 ( 0.00% ) | 4 M $ | 2024-05-30 |
Latest news about Emma Walmsley
Emma Walmsley active positions
Companies | Position | Start |
---|---|---|
GSK PLC | Chief Executive Officer | 2017-03-31 |
MICROSOFT CORPORATION | Director/Board Member | 2019-11-30 |
Glaxosmithkline Australia Pty Ltd.
Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Chief Executive Officer | - |
Stanford Medicine
Stanford Medicine Hospital/Nursing ManagementHealth Services Stanford Medicine is an integrated academic health system that includes the Stanford School of Medicine and adult and pediatric health care delivery systems. The private company is based in Stanford, CA. The company focuses on collaborative research, education, and clinical care for patients to harness the full potential of biomedicine. | Corporate Officer/Principal | - |
Former positions of Emma Walmsley
Companies | Position | End |
---|---|---|
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Director/Board Member | 2022-07-17 |
DIAGEO PLC | Director/Board Member | 2016-09-20 |
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The company is based in Singapore, Singapore. | Chief Executive Officer | - |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK. | Chief Executive Officer | - |
L'Oreal (China) Co., Ltd.
L'Oreal (China) Co., Ltd. Household/Personal CareConsumer Non-Durables Part of L'Oréal SA, L'Oreal (China) Co., Ltd. manufactures and markets personal care products. Fabrice Megarbane has been the CEO of the Chinese company since 2000. | Corporate Officer/Principal | - |
Training of Emma Walmsley
University of Oxford | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
GSK PLC | Health Technology |
DIAGEO PLC | Consumer Non-Durables |
MICROSOFT CORPORATION | Technology Services |
Private companies | 6 |
---|---|
L'Oreal (China) Co., Ltd.
L'Oreal (China) Co., Ltd. Household/Personal CareConsumer Non-Durables Part of L'Oréal SA, L'Oreal (China) Co., Ltd. manufactures and markets personal care products. Fabrice Megarbane has been the CEO of the Chinese company since 2000. | Consumer Non-Durables |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK. | Finance |
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The company is based in Singapore, Singapore. | Consumer Non-Durables |
Glaxosmithkline Australia Pty Ltd.
Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Finance |
Stanford Medicine
Stanford Medicine Hospital/Nursing ManagementHealth Services Stanford Medicine is an integrated academic health system that includes the Stanford School of Medicine and adult and pediatric health care delivery systems. The private company is based in Stanford, CA. The company focuses on collaborative research, education, and clinical care for patients to harness the full potential of biomedicine. | Health Services |
- Stock Market
- Insiders
- Emma Walmsley